contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

MedCap är verksamt inom investeringsbranschen och fokuserar på långsiktiga ägarinvesteringar i medicinteknik- och läkemedelsföretag. Bolagets portfölj inkluderar företag inom sektorer som bioteknik och medicinteknik. Verksamheten är främst koncentrerad till Sverige, med en huvudsaklig närvaro i Stockholmsregionen. MedCap grundades 2001 och har sitt huvudkontor i Stockholm.

MedCap

Abilia, a subsidiary to MedCap AB (publ) and part of Business Area Assistive Tech, has signed an agreement to acquire LivAssured B.V. in the Netherlands. The transaction is expected to close...

Abilia, a subsidiary to MedCap AB (publ) and part of Business Area Assistive Tech, has signed an agreement to acquire LivAssured B.V. in the Netherlands. The transaction is expected to close shortly.LivAssured's product Nightwatch is a medical device that detects epileptic seizures, and has been developed for more than 10 years with significant commercial progress achieved in Europe in recent years. The company currently has a turnover of approx. 4 MEUR and 15 employees, and an ambitious growth plan. The acquisition complements the offering of Abilia and the Business Area Assistive Tech. Tove Christiansson, Head of Business Area Assistive Tech and CEO of Abilia comments the acquisition: "Abilia's mission has always been to empower people through innovative, reliable, and user centric assistive technology", says Tove Christiansson,&nbsp;"With this acquisition, we're deepening that mission, reinforcing our dedication to delivering solutions that truly matter, grounded in evidence, and built through collaboration with key stakeholders. We look forward to welcoming the LivAssured team to Abilia and the Business Area Assistive Tech."Jeroen van den Hout, CEO of LivAssured comments the acquisition: &nbsp;"We are very proud of what we've achieved with our partners in the epilepsy community," says Jeroen van den Hout "Joining Abilia allows us to scale our impact and continue delivering trusted, research-based solutions to even more people across Europe and beyond."The purchase price consists of an initial cash payment of 9.5 MEUR at closing and a deferred payment of 0.5 MEUR for 100% of the company's shares, and a potential additional payment of up to 4 MEUR contingent upon the gross profit growth in 2026. The acquisition is expected to have a marginally positive impact on MedCap's earnings during the current financial year.<div>This disclosure contains information that MedCap AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 01-10-2025 15:00 CEST.</div>

MedCap AB: Abilia acquires LivAssured

USA:s Black Week ledde till överraskande inköp

Måste man arbeta långa dagar? Ekonomen funderar

Uppgångsvecka bakom oss, Tyskland gick vidare med sin megabudget

Finlands ekonomiska tillväxt: ”Varje dag och varje natt tänker jag på dig”

Nedgångsvecka bakom oss, AI-oron når även obligationsmarknaden